TrialCancer research and treatment2024

Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.

Sehhoon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.